AAV-based gene therapy (Aevitas)

N/A

Report date: 2025/01/26 18:11:36

Base Information

Drug NameAAV-based gene therapy (Aevitas)
Drug Alias NameAVTS-001
ClassificationBiologics
Mechanisms of ActionComplement system proteins modulators
TargetsComplement system proteins
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAevitas Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAevitas Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A